Changes in DNA copy number in primary gastric carcinomas by comparative genomic hybridization

Clinical Cancer Research

Volumn 3, Issue 7, 1997, Pages 1067-1076

  Koizumi, Yoko ^a   Tanaka, Shun Ichi ^a   Mou, Reiko ^a   Koganei, Hiroyuki ^a   Kokawa, Atsushi ^a   Kitamura, Reiko ^a   Yamauchi, Hiroyo ^a   Ookubo, Kenji ^a   Saito, Toshifumi ^a   Tominaga, Shizuo ^a   Matsumura, Kouji ^b   Shimada, Hiroshi ^a   Tsuchida, Nobuo ^b   Sekihara, Hisahiko ^a  

^a YOKOHAMA CITY UNIVERSITY   (Japan)

^b TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CHROMOSOME 2P; CHROMOSOME 3Q; CHROMOSOME 7P; CHROMOSOME 9Q; CLINICAL ARTICLE; FEMALE; GENE LOCATION; GENE REARRANGEMENT; GENETIC LINKAGE; HUMAN; IN SITU HYBRIDIZATION; MALE; PRIORITY JOURNAL; STOMACH CARCINOGENESIS; STOMACH CARCINOMA;

ADULT; AGED; CHROMOSOME ABERRATIONS; CHROMOSOME MAPPING; CHROMOSOMES, HUMAN, PAIR 1; CHROMOSOMES, HUMAN, PAIR 13; CHROMOSOMES, HUMAN, PAIR 2; CHROMOSOMES, HUMAN, PAIR 3; CHROMOSOMES, HUMAN, PAIR 7; CHROMOSOMES, HUMAN, PAIR 9; FEMALE; HUMANS; IN SITU HYBRIDIZATION; KARYOTYPING; LIVER NEOPLASMS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM STAGING; STOMACH NEOPLASMS; Y CHROMOSOME;

EID: 0030814084     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (53)

1. Ochi, H., Douglass, H. J., and Sandberg, A. A. Cytogenetic studies in primary gastric cancer. Cancer Genet. Cytogenet., 22: 295-307, 1986.
2. Ferti, P. A., Panani, A. D., Vlachos, J. D., and Raptis, S. A. Common cytogenetic findings in gastric cancer. Cancer Genet. Cytogenet., 24: 63-73, 1987.
3. Rodriguez, E., Rao, P. H., Ladanyi, M., Altorki, N., Albino, A. P., Kelsen, D. P., Jhanwar, S. C., and Chaganti, R. S. 11p13-15 is a specific region of chromosomal rearrangement in gastric and esophageal adenocarcinomas. Cancer Res., 50: 6410-6416, 1990.
4. Abarbanel, J., Shabtai, F., Kyzer, S., and Chaimof, C. Cytogenetic studies in patients with gastric cancer. World J. Surg., 15: 778-782, 1991.
5. Seruca, R., Castedo, S., Correia, C., Gomes, P., Carneiro, F., Soares, P., de Jong, B., and Sobrinho-Simões, M. Cytogenetic findings in 11 gastric carcinomas. Cancer Genet. Cytogenet., 68: 42-48, 1993.
6. Wada, M., Yokota, J., Mizoguchi, H., Sugimura, T., and Terada, M. Infrequent loss of chromosomal heterozygosity in human stomach cancer. Cancer Res., 48: 2988-2992, 1988.
7. Sano, T., Tsujino, T., Yoshida, K., Nakayama, H., Mamma, K., Ito, H., Nakamura, Y., Kajiyama, G., and Tahara, E. Frequent loss of heterozygosity on chromosomes 1q, 5q, and 17p in human gastric carcinomas. Cancer Res., 51: 2926-2931, 1991.
8. Kallioniemi, A., Kallioniemi, O. P., Sudar, D., Rutovitz, D., Gray, J. W., Waldman, F., and Pinkel, D. Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors. Science (Washington DC), 258: 818-821, 1992.
9. Kallioniemi, O. P., Kallioniemi, A., Sudar, D., Rutovitz, D., Gray, J. W., Waldman, F., and Pinkel, D. Comparative genomic hybridization: a rapid new method for detecting and mapping DNA amplification in tumors. Semin. Cancer Biol., 4: 41-46, 1993.
10. Manoir, S. D., Speicher, M. R., Joos, S., Schrock, E., Popp, S., Dohner, H., Kovacs, G., Robert, N. M., Lichter, P., and Cremer, T. Detection of complete and partial chromosome gains and losses by comparative genomic in situ hybridization. Hum. Genet., 90: 590-610, 1993.
11. Schrock, E., Thiel, G., Lozanova, T., Manoir, S. D., Meffert, M. C., Jauch, A., Speicher, M. R., Nurnberg, P., Vogel, S., Janisch, W., et al. Comparative genomic hybridization of human malignant gliomas reveals multiple amplification sites and nonrandom chromosomal gains and losses. Am. J. Pathol., 144: 1203-1218, 1994.
12. Kallioniemi, O. P., Kallioniemi, A., Piper, J., Isola, J., Waldman, F. M., Gray, J. W., and Pinkel, D. Optimizing comparative genomic hybridization for analysis of DNA sequence copy number changes in solid tumors. Genes Chromosomes & Cancer, 10: 231-243, 1994.
13. The General Rules for the Gastric Cancer Study, 12th edition. Japanese Research Society for Gastric Cancer, 1993.
14. TNM Classification of Malignant Tumors, 4th edition. Geneva: International Union Against Cancer, 1987.
15. Kallioniemi, A., Kallioniemi, O. P., Piper, J., Tanner, M., Stokke, T., Chen, L., Smith, H. S., Pinkel, D., Gray, J. W., and Waldman, F. M. Detection and mapping of amplified DNA sequences in breast cancer by comparative genomic hybridization. Proc. Natl. Acad. Sci. USA. 91: 2156-2160, 1994.
16. Levin, N. A., Brzoska, P. M., Warnock, M. L., Gray, J. W., and Christman, M. F. Identification of novel regions of altered DNA copy number in small cell lung tumors. Genes Chromosomes & Cancer, 13: 175-185, 1995.
17. Speicher, M. R., Prescher, G., Manoir, S. D., Jauch, A., Horsthemke, B., Bornfeld, N., Becher, R., and Cremer, T. Chromosomal gains and losses in uveal melanomas detected by comparative genomic hybridization. Cancer Res., 54: 3817-3823, 1994.
18. Visakorpi, T., Kallioniemi, A. H., Syvanen, A. C., Hyytinen, E. R., Karhu, R., Tammela, T., Isola, J. J., and Kallioniemi, O. P. Genetic changes in primary and recurrent prostate cancer by comparative genomic hybridization. Cancer Res., 55: 342-347, 1995.
19. Speicher, M. R., Howe, C., Crotty, P., Manoir, S. D., Costa, J., and Ward, D. C. Comparative genomic hybridization detects novel deletions and amplifications in head and neck squamous cell carcinomas. Cancer Res., 55: 1010-1013, 1995.
20. Tarkkanen, M., Karhu, R., Kallioniemi, A., Elomaa, I., Kivioja, A. H., Nevalainen, J., Bohling, T., Karaharju, E., Hyytinen, E., Knuutila, S., and Kallioniemi, O-P. Gains and losses of DNA sequences in osteosarcomas by comparative genomic hybridization. Cancer Res., 55: 1334-1338, 1995.
21. Yonemura, Y., Ninomiya, I., Ohoyama, S., Kimura, H., Yamaguchi, A., Fushida, S., Kosaka, T., Miwa, K., Miyazaki, L. Endou, Y., et al. Expression of c-erbB-2 oncoprotein in gastric carcinoma. Immunoreactivity for c-erbB-2 protein is an independent indicator of poor short-term prognosis in patients with gastric carcinoma. Cancer (Phila.), 67: 2914-2918, 1991.
22. Mizutani, T., Onda, M., Tokunaga, A., Fujita, I., Okuda, T., Iida, S., Kiyama, T., Nishi, K., Matsukura, N., Yamashita, K., et al. Correlation of c-erbR-2 with invasion and metastasis in human gastric cancer. Gastroenterol. Jpn., 27: 424, 1992.
23. Sasaki, K., Tomita, Y., Azuma, M., Shida, S., and Shimizu, B. Amplification and overexpression of the c-erbB-2 proto-oncogene in human gastric cancer. Gastroenterol. Jpn., 27: 172-178, 1992.
24. David, L., Seruca, R., Nesland, J. M., Soares, P., Sansonetty, F., Holm, R., Borresen, A. L., and Sobrinho, S. M. c-erbB-2 expression in primary gastric carcinomas and their metastases. Mod. Pathol., 5: 384-390, 1992.
25. Tsugawa, K., Fushida, S., and Yonemura, Y. Amplification of the c-erbB-2 gene in gastric carcinoma: correlation with survival. Oncology (Basel), 50: 418-425, 1993.
26. Noguchi, Y., Tsuburaya, A., Makino, T., Fukuzawa, K., Nomura, K., Yoshikawa, T., Imada, T., Amano, T., and Matsumoto, A. Predictive value of c-erbB-2 and DNA ploidy patterns in gastric carcinoma recurrence. Int. Surg., 78: 107-111, 1993.
27. Motojima, K., Furui, J., Kohara, N., Izawa, K., Kanematsu, T., and Shiku, H. erbB-2 expression in well-differentiated adenocarcinoma of the stomach predicts shorter survival after curative resection. Surgery (St. Louis). 115: 349-354, 1994.
28. Ranzani, G. N., Renault, B., Pellegata, N. S., Fattorini, P., Magni, E., Bacci, F., and Amadori, D. Loss of heterozygosity and K-ras gene mutations in gastric cancer. Hum. Genet., 92: 244-249, 1993.
29. Uchino, S., Tsuda, H., Noguchi, M., Yokota, J., Terada, M., Saito, T., Kobayashi, M., Sugimura, T., and Hirohashi, S. Frequent loss of heterozygosity at the DCC locus in gastric cancer. Cancer Res., 52: 3099-3102, 1992.
30. Horii, A., Nakatsuru, S., Miyoshi, Y., Ichii, S., Nagase, H., Kato, Y., Yanagisawa, A., and Nakamura, Y. The APC gene, responsible for familial adenomatous polyposis, is mutated in human gastric cancer. Cancer Res., 52: 3231-3233, 1992.
31. Nakatsuru, S., Yanagisawa, A., Ichii, S., Tahara, E., Kato, Y., Nakamura, Y., and Horii, A. Somatic mutation of the APC gene in gastric cancer: frequent mutations in very well-differentiated adenocarcinoma and signet-ring cell carcinoma. Hum. Mol. Genet., 1: 559-563, 1992.
32. Nakatsuru, S., Yanagisawa, A., Furukawa, Y., Ichii, S., Kato, Y., Nakamura, Y., and Horii, A. Somatic mutations of the APC gene in precancerous lesion of the stomach. Hum. Mol. Genet., 2: 1463-1465, 1993.
33. Tamura, G., Maesawa, C., Suzuki, Y., Tamada, H., Satoh, M., Ogasawara, S., Kashiwaba, M., and Satodate, R. Mutations of the APC gene occur during early stages of gastric adenoma development. Cancer Res., 54: 1149-1151, 1994.
34. Ayhan, A., Yasui, W., Yokozaki, H., Seto, M., Ueda, R., and Tahara, E. Loss of heterozygosity at the bcl-2 gene locus and expression of bcl-2 in human gastric and colorectal carcinomas. Jpn. J. Cancer Res., 85: 584-591, 1994.
35. Lauwers, G. Y., Scott, G. V., and Karpeh, M. S. Immunohistochemical evaluation of bcl-2 protein expression in gastric adenocarcinomas. Cancer (Phila.), 75: 2209-2213, 1995.
36. Lemoine, N. R., Jain, S., Silvestre, F., Lopes, C., Hughes, C. M., McLelland, E., Gullick, W. J., and Filipe, M. I. Amplification and overexpression of the EGF receptor and c-erbB-2 proto-oncogenes in human stomach cancer. Br. J. Cancer, 64: 79-83, 1991.
37. Kameda, T., Yasui, W., Tsujino, T., Nakayama, H., Ayhan, A., Ito, H., and Tahara, E. Tyrosine kinase activity of epidermal growth factor receptor in human gastric carcinomas. Pathol. Res. Pract., 188: 37-43, 1992.
38. Tokunaga, A., Onda, M., Okuda, T., Teramoto, T., Fujita, I., Mizutani, T., Kiyama, T., Yoshiyuki, T., Nishi, K., and Matsukura, N. Clinical significance of epidermal growth factor (EGF), EGF receptor, and c-erbB-2 in human gastric cancer. Cancer (Phila.), 75: 1418-1425, 1995.
39. Hattori, Y., Odagiri, H., Nakatani, H., Miyagawa, K., Naito, K., Sakamoto, H., Katoh, O., Yoshida, T., Sugimura, T., and Terada, M. K-sam, an amplified gene in stomach cancer, is a member of the heparin-binding growth factor receptor genes. Proc. Natl. Acad. Sci. USA, 87: 5983-5987, 1990.
40. Nakatani, H., Sakamoto, H., Yoshida, T., Yokota, J., Tahara, E., Sugimura, T., and Terada, M. Isolation of an amplified DNA sequence in stomach cancer. Jpn. J. Cancer Res., 81: 707-710, 1990.
41. Mor, O., Ranzani, G. N., Ravia, Y., Rotman, G., Gutman, M., Manor, A., Amadori, D., Houldsworth, J., Hollstein, M., Schwab, M., et al. DNA amplification in human gastric carcinomas. Cancer Genet. Cytogenet., 65: 111-114, 1993.
42. Kuniyasu, H., Yasui, W., Kitadai, Y., Yokozaki, H., Ito, H., and Tahara, E. Frequent amplification of the c-met gene in scirrhous type stomach cancer. Biochem. Biophys. Res. Commun., 189: 227-232, 1992.
43. Rege, C. G., Scaravaglio, P., Carozzi, F., Giordano, S., Ponzetto, C., Comoglio, P. M., and Saglio, G. Karyotypic analysis of gastric carcinoma cell lines carrying an amplified c-met oncogene. Cancer Genet. Cytogenet., 64: 170-173, 1992.
44. Yamada, Y., Yoshida, T., Hayashi, K., Sekiya, T., Yokota, J., Hirohashi, S., Nakatani, K., Nakano, H., Sugimura, T., and Terada, M. p53 gene mutations in gastric cancer metastases and in gastric cancer cell lines derived from metastases. Cancer Res., 51: 5800-5805, 1991.
45. Kim, J. H., Takahashi, T., Chiba, I., Park, J. G., Birrer, M. J., Roh, J. K., De, L. H., Kim, J. P., Minna, J. D., and Gazdar, A. F. Occurrence of p53 gene abnormalities in gastric carcinoma tumors and cell lines. J. Natl. Cancer Inst., 83: 938-943, 1991.
46. Matozaki, T., Sakamoto, C., Suzuki, T., Matsuda, K., Uchida, T., Nakano, O., Wada, K., Nishisaki, H., Konda, Y., Nagao, M., and Kasuga, M. p53 gene mutations in human gastric cancer: wild-type p53 but not mutant p53 suppresses growth of human gastric cancer cells. Cancer Res., 52: 4335-4341, 1992.
47. Matozaki, T., Sakamoto, C., Matsuda, K., Suzuki, T., Konda, Y., Nakano, O., Wada, K., Uchida, T., Nishisaki, H., Nagao, M., et al. Missense mutations and a deletion of the p53 gene in human gastric cancer. Biochem. Biophys. Res. Commun., 182: 215-223, 1992.
48. Renault, B., van den Broek, M., Fodde, R., Wijnen, J., Pellegata, N. S., Amadori, D., Khan, P. M., and Ranzani, G. N. Base transitions are the most frequent genetic changes at P53 in gastric cancer. Cancer Res., 53: 2614-2617, 1993.
49. DeVries, S., Gray, J. W., Pinkel, D., Waldman, F. M., and Sudar, D. Comparative Genomic Hybridization. In: Current Protocols In Human Genetics. Suppl. 6, pp. 4.6.1-4.6.18. New York: John Wiley & Sons, Inc., 1995.
50. Castedo, S., Correia, C., Gomes, P., Seruca, R., Soares, P., Cameiro, F., and Sobrinho, S. M. Loss of Y chromosome in gastric carcinoma. Fact or artifact? Cancer Genet. Cytogenet., 61: 39-41, 1992.
51. Saal, K., Vollmers, H. P., Muller, J., Kohler, J., Hohn, H., and Muller, H. H. Cytogenetic differences between intestinal and diffuse types of human gastric carcinoma. Virchows Arch. B Cell Pathol. Incl. Mol. Pathol., 64: 145-150, 1993.
52. Tahara, E. Molecular mechanism of stomach carcinogenesis. J. Cancer Res. Clin. Oncol., 119: 265-272, 1993.
53. Tahara, E. Molecular biology of gastric cancer. World J. Surg., 19: 484-488, 1995.